Due to the complex nature of clinical studies, the huge costs in double blind studies, and the huge gap between normalized clinical studies and 3rd world availabilities, Aids Research & Assistance (ARAI) uses anecdotal studies which bring a general understanding of a product’s capabilities, as perceived by those taking the product and those administering the product. Round 1 & 2 U.S. based, 90 days, 100 individuals with various diseases and ailments including HIV/AIDS, various cancers including breast cancer, prostate cancer, Lymphoma, bone cancer, arthritis, diabetes, hepatitis C, athlete’s foot and more. Round 1 & 2 consisted of implementing 2 scoops of product (scoop enclosed in canister) per day in water, cereal, foods, etc. Patients filled out a full health survey concerning their current ailments, physical and mental condition, pain levels and hopes for what Flax Hull Lignans could help accomplish by strengthening the immune system. Patients agreed to not change medications or lifestyle during the 90 day process. Patients delivered a 30, 60 and 90 day report giving any noticed changes in health, condition of ailments, etc. During round 1, we realized that 15% of the patients were experiencing constipation with the fibrous content of Flax Hull Lignans. Those 15% either found a way to increase daily water consumption or they backed down to 1 scoop of product per day.
76% of patients studied found some type of positive response to the product study within 30 days, many responses were dramatic. 52% of patients had a positive response within the first 30 days, and 91% of patients studied had a positive response to the product study within 90 days. Responses included dramatic reduction in size of cancers, reduction in insulin needs with diabetics and blood sugar levels coming into order, HIV/AIDS symptoms decreasing or disappearing, general feeling of vitality, HIV CD4 counts strengthening and viral loads diminishing. 10% of patients noticed no change in health during the 90 day study. Round 2 brought about 1 change only. During round 1, we noticed that among those who backed down their dosage to 1 scoop per day because of constipation issues, those patients still had very positive responses to the product. Therefore, the second 100 patients on Round 2 received only 1 scoop of product per day for 90 days. The results came in exactly the same with 55% of patients having a positive response within the first 30 days, and 90% having a positive response within 90 days, and 0% constipation issues in the group.
It was further realized through Round 1 and 2, that those whom had dramatic changes in health during the first 30 days maintained those changes in health through the entire 90 day period, and most of the impact occurred within the first 30 days of the study. Those with dramatic 30 day results had only minimal continued change through the 60 and 90 day period, but maintained the result gained within the first 30 days. Most changes that were going to occur within the 90 day period – did indeed occur for those patients within the first 30 days.
Round 3 was performed in Durban, South Africa, Piet Retief, South Africa and Swaziland (highest AIDS pandemic areas globally). The 90 day study included 1 scoop of product per day for adults and 1/2 scoop of product per day for children 12 and under. All 100 patients were HIV Positive and 75% experienced AIDS symptoms including (cancer, thrush, mental fatigue and lack of focus, diminished strength, swelling of glands and other various AIDS related symptoms). The African
people responded more quickly to the study, with 64% having a health change within the first 30 days, and 97% noticing a positive health change within the 90 day study. The higher levels of response were very interesting, and our group could only suppose that the powerful nutritional values of the flax lignan product helped them to increase weight and height, as well as recover from many symptoms of HIV/AIDS. We are pleased to announce that after 3 rounds of loosely knit studies, we are absolutely confident in the power of Flax Hull Lignans, and their ability to do what we had supposed in the beginning. ARAI has continued to ship flax lignans into the hardest hit rural areas of South Africa and Swaziland with future plans of distribution in other areas of Africa as supply and funding permits.
IMPACT ON APATHETIC AFRICAN SOCIETY The impact of Round 3 study on the African people was dramatic. Both those who were a part of the Round 3 program, and those who administered the program became intensely interested in how to get increased amounts of this product. The general mindset of the grass roots African society is one of apathy concerning HIV/AIDS because there seems to be absolutely “NO” cure, help or reasonable treatment to help one afflicted. ARAI representatives have noticed the following in Africa: 1. HIV/AIDS is truly at pandemic level in the continent of Africa with societies such as South Africa dealing with multiplied millions infected including millions of children/orphans, spanning from tribal Zulu’s to middle and upper class college students in larger cities. The nation of Swaziland is faced with the challenge of national extinction by 2050 if some answer is not delivered before then. Other nations face the same horrific futures if an answer is not given. 2. The medications that have been made available by the U.S. and other nations are not reasonable for impoverished rural South Africans infected because: a. The reduced cost of the anti-retroviral meds still have a cost to the rural individual, which is up to 3 times the monthly income of an infected rural South African (if they are able to work). Therefore the meds aren’t being distributed because they’re unaffordable or the rural people don’t know that they’re available. b. The power of the meds requires adherence to time sensitive administration and proper storage of some of the meds. Many of those infected don’t have a watch, let alone operate by an hourly – time sensitive mind set. 3. The main program model that seems to be predominant in the African nations is one of “education”. While this is extremely important to curb the pandemic from spreading to non-infected, there is a huge gap which millions are falling into after they’ve been infected with HIV. It seems that as long as a person is not infected with HIV, there are resources and education available to help a person or community understand how to “not” get HIV. However, for those millions already infected, there is little hope, little resource and seeming little attention given – as they’re the ones with the death sentence written. a. There is a huge clash between the current educational programs and the Zulu nation historic beliefs and traditions. Many won’t adhere to the educational programs because of long time traditional beliefs and lifestyle among many, therefore the infection rates continue to increase. 4. The age ranges most affected by this pandemic include the working class age group, leaving behind only the elderly and orphans – as is the case of Swaziland which faces extinction in 2025 if an answer is not provided. ANSWERS: ARAI believes that with the implementation of Flax Hull Lignans into the diet of HIV/AIDS patients, as well as the entire general population for increased immune system strength, that the overall immune health of all involved would strengthen, production levels would increase among the work force and market place, AIDS symptoms would diminish and those who are currently being discarded with no hope could find a place of increased auto-immune health, vitality and a return to social productivity.
Currently, ARAI is shipping flax lignans into South Africa and Swaziland, with future shipments to include Zimbabwe and other African nations. Product is being given free of charge to orphans and children with AIDS, as well as HIV positive parents who have children depending on their health and income for living. ARAI has multiple relationships with governing officials, health practitioners, business owners, corporate CEO’s, and relief organizations in the African nations who are moving forward in belief that the answers are “AT HAND AND AVAILABLE”. Flax Hull Lignans are a part of that answer to restore health to the African populations.
For further information on ARAI health programs and initiatives, please contact Dr. Daniel Daves at email@example.com or 314-397-2580. WEB SITE: www.aidshivawareness.org